‘*’ Those authors contributed equally.
Selected Publications
‘*’ Those authors contributed equally.
Latest News
Apr 2021: Representation Learning for Biomedical Nets
In our survey on representation learning for biomedical networks we discuss how long-standing principles of network biology and medicine provide the conceptual grounding for representation learning, explain its successes, and inform future advances.
Mar 2021: Receiving Amazon Research Award
We are excited about receiving Amazon Faculty Research Award on Actionable Graph Learning for Finding Cures for Emerging Diseases. Thank you to Amazon Science for supporting our research.
Mar 2021: Michelle's Graduate Research Fellowship
Michelle M. Li won the NSF Graduate Research Fellowship Award. Congratulations!
Mar 2021: Hot Off the Press: Multiscale Interactome
Hot off the press! We develop a multiscale interactome approach to explain disease treatments. The approach can predict drug-disease treatments, identify proteins and biological functions related to treatment, and identify genes that alter treatment’s efficacy and adverse reactions.
Mar 2021: Graph Networks in Computational Biology
We are excited to share slides from our recent lecture on Graph Neural Networks in Computational Biology, which we gave at Stanford ML for Graphs course.
Mar 2021: Fair and Stable Graph Representation Learning
We are thrilled to share the latest preprint on fair and stable graph representation learning.
Feb 2021: New Preprint on Therapeutics Data Commons
We are excited to share the preprint on Therapeutics Data Commons: Machine Learning Datasets and Tasks for Therapeutics. TDC is available at http://tdcommons.ai.
Jan 2021: An Algorithmic Approach to Patient Safety
The new algorithmic approach investigates population-scale patient safety data and reveals inequalities in adverse events before and during COVID-19 pandemic.
Jan 2021: Workshop on AI in Health at the Web Conference
We are excited to co-organize Workshop on AI in Health: Transferring and Integrating Knowledge for Better Health at the Web (WWW) conference. The call for papers is open! We also announce the AI in Health Data Challenge.
Jan 2021: Tutorial on ML for Drug Development
We will present a tutorial on ML/AI for drug discovery and development at IJCAI conference. See the tutorial website.
Dec 2020: Two New Papers Published
We are excited to see published our paper on DeepPurpose, a deep learning library for drug-target interaction prediction, and our paper on skipGNN, a graph neural network for predicting molecular interactions.
Dec 2020: Bayer Early Excellence in Science Award
Our research won the Bayer Early Excellence in Science Award. We are honored to have received this recognition!
Nov 2020: Therapeutics Data Commons (TDC)
We are thrilled to announce Therapeutics Data Commons (TDC)! We invite you to join TDC. TDC is an open-source and community-driven effort.
Nov 2020: National Symposium on the Future of Drugs
On behalf of the NSF, we are organizing the National Symposium on Drug Repurposing for Future Pandemics. We have a stellar lineup of invited speakers! Register at www.drugsymposium.org.
Oct 2020: MARS: Novel Cell Types in Single-cell Datasets
Hot off the press! MARS, an approach for discovering novel cell types across heterogeneous single-cell experiments is just published in Nature Methods.
Sep 2020: MITxHarvard Women in AI Interview
The MITxHarvard Women in AI initiative talked with Marinka about AI, machine learning, and the role of new technologies in biomedical research.
Aug 2020: Trustworthy AI for Healthcare
We are excited to be co-organizing a workshop at AAAI 2021 on Trustworthy AI for Healthcare! We have a stellar lineup of speakers. Details to follow soon!
Aug 2020: Network Drugs for COVID-19
What are network drugs? Drugs for COVID-19 predicted by network medicine, our graph neural networks (GNNs), and our rank aggregation algorithms, followed by experimental confirmations. The full paper is finally out!
Jul 2020: Podcast on ML for Drug Development
Tune in to the podcast with Marinka about machine learning to drug development. The discussion focuses on open research questions in the field, including how to limit the search space of high-throughput screens, design drugs entirely from scratch, and identify likely side-effects of combining drugs in novel ways.
Tweets